Navigation Links
Hospira Board Authorizes $1 Billion Share Repurchase Program
Date:4/25/2011

LAKE FOREST, Ill., April 25, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that its board of directors has authorized the repurchase of up to $1 billion of the company's common stock.

"This share repurchase program underscores our continued belief and optimism in Hospira's long-term growth prospects, as well as our commitment to return value to our shareholders," said F. Michael Ball, chief executive officer. "The share repurchase is one component of our planned uses of cash and capital structure, which we will update as scheduled when we announce our first-quarter 2011 results on April 26."

The multi-year program authorizes the company to repurchase common shares from time to time through the open market and through private transactions in compliance with securities regulations and other legal requirements. The size and timing of any purchases are at the discretion of company management, based on factors such as price, business and market conditions. The program does not have an expiration date.

The new authorization is the second share-repurchase authorization for the company. The first authorization, for $400 million of the company's common stock, was announced in February 2006 and recently completed.

For the three months ended Dec. 31, 2010, the company had approximately 170.1 million weighted average shares of common stock outstanding.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.

Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Hospira's intention to repurchase shares of its stock. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements, including uncertainties as to the market price of Hospira's stock, market conditions in general and Hospira's future operating performance.  Economic, competitive, governmental, regulatory, legal, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form 10-K and subsequent Forms 10-Q filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
2. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
3. Hospira to Host Conference Call for First-Quarter 2011 Results
4. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
5. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
6. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
7. Hospira Announces U.S. Approval of Generic Docetaxel
8. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
9. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
10. Hospira to Present at Upcoming Investor Conferences
11. Hospira Announces FDA Approval of Topotecan Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... WARSAW, Ind. , April 20, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Health Care Conference at the InterContinental Hotel in ... 2017.  Zimmer Biomet will present at 11:20 a.m. Eastern ... can be accessed via Zimmer Biomet,s Investor Relations website ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, ... today unveiled a new store design to enhance ... of healthier food, health-focused products and expanded beauty ... to help customers discover new offerings. Together with ... next evolution of the customer experience at CVS ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often ... it difficult for lab operators and management to assess these processes with a ... wasteful or unnecessary actions. , Created with the help of both internal ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... “Learning to ... to navigate life. “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” ... for various nonprofits, former Chairman of the Board of Directors for CONTACT USA, and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Insect ... distributors and International relief organizations across the globe to provide effective protection against ... and work wear collections via insectshield.com . In the wake of the ...
(Date:4/23/2017)... ... April 23, 2017 , ... ... services announced the achievement of Cisco Select certification and SMB specialization. Altura ... States. , In earning the Select Certification, Altura fulfilled the training ...
(Date:4/22/2017)... ... April 22, 2017 , ... Brian Emmer brings more ... Sales and Business Development at OAKWORKS, Inc. Mr. Emmer is responsible for ... strategic planning for the company. Recognized industry-wide as a healthcare innovator, Emmer ...
Breaking Medicine News(10 mins):